Literature DB >> 6333390

Modulation of T-cell antigen receptor on lymphocyte membrane.

R Haars, C Rohowsky-Kochan, E Reed, D W King, N Suciu-Foca.   

Abstract

A mouse monoclonal antibody, Mo. Ab. 108.45, detecting cell-surface determinants associated with the T-cell receptor for alloantigen was produced by immunizing mice with an alloreactive human T-cell clone and fusing the splenocytes with the NS1 plasmocytoma. This Mo. Ab. reacts with the immunizing T-cell clone but not with autologous or allogeneic lymphocytes, lymphoblasts or monocytes; stimulates the proliferation of the immunizing T cells in the absence of the alloantigen; inhibits the response to the specific stimulator; and precipitates a disulfied linked heterodimer composed of two distinct glycoproteins of molecular weights 40000 and 46000. The receptor molecule detected by Mo. Ab. 108.45 modulates on the surface of the cells, reaching the highest levels 5 days following exposure to the specific stimulator. The receptor-associated molecule detected by Mo. Ab. 108.45 was expressed by T-cell clones obtained independently in two different mixed lymphocyte cultures between the same responder and stimulator.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333390     DOI: 10.1007/bf00345614

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  18 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Isolation of cDNA clones encoding T cell-specific membrane-associated proteins.

Authors:  S M Hedrick; D I Cohen; E A Nielsen; M M Davis
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

4.  Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins.

Authors:  S M Hedrick; E A Nielsen; J Kavaler; D I Cohen; M M Davis
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

5.  The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors.

Authors:  O Acuto; R E Hussey; K A Fitzgerald; J P Protentis; S C Meuer; S F Schlossman; E L Reinherz
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

6.  The mouse T cell receptor: comparison of MHC-restricted receptors on two T cell hybridomas.

Authors:  J Kappler; R Kubo; K Haskins; J White; P Marrack
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

7.  Identification of D segments of immunoglobulin heavy-chain genes and their rearrangement in T lymphocytes.

Authors:  Y Kurosawa; H von Boehmer; W Haas; H Sakano; A Trauneker; S Tonegawa
Journal:  Nature       Date:  1981-04-16       Impact factor: 49.962

8.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.

Authors:  Y Yanagi; Y Yoshikai; K Leggett; S P Clark; I Aleksander; T W Mak
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

9.  Inducible expression of insulin receptors on T lymphocyte clones.

Authors:  V L Braciale; J R Gavin; T J Braciale
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

10.  Helper and killer T cells do not express B cell immunoglobulin joining and constant region gene segments.

Authors:  M Kronenberg; M M Davis; P W Early; L E Hood; J D Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  2 in total

1.  NDA3: a differentiation antigen associated with the receptor for B cell growth factor.

Authors:  N Suciu-Foca; C Rohowsky-Kochan; S J Rosochacki; E Cristea; J D Cai; E Reed; D W King
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

2.  Amplification of T cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome.

Authors:  P E Harris; K Strba-Cechova; P Rubinstein; D Mann; D W King; N Suciu-Foca
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.